News

Under the agreement, BioLineRx acquires all rights to develop, sub-license and commercialise the compound. BioLineRx will cover all future costs of the program. Santhera will receive 22% to

As part of the realignment, around 10 and 15 employees will move from Birmingham to Durham. This will result in the elimination of eight jobs, which will be

Under the brand name Conbriza, the drug will also be marketed in Spain through a co-promotion with Almirall, an international pharmaceutical company based in Spain. Viviant, a selective

Nefecon is an oral small molecule product which downregulates the inflammatory process in the kidneys. Nefecon is being co-developed by Pharmalink and Archimedes Pharma under a partnership agreed

The grant is in response to the solicitation ‘Recovery Act Limited Competition: NIH Director’s Opportunity for Research in Five Thematic Areas (RC4),’ funded by the American Recovery and

The agreement allows Lundbeck to gain access to Genmab’s antibody creation and development capabilities, including its fully automated pre-clinical antibody screening and characterisation capabilities and its proprietary stabilised

The patent, titled ‘Composition and Use of Phyto-Percolate for the Treatment of Disease,’ describes the general makeup of PAZ and its ability to address a variety of common

COU-AA-301 study was conducted in patients with metastatic advanced prostate cancer (also referred to as castration-resistant prostate cancer, or CRPC) previously treated with one or two chemotherapy regimens,

Natural Health Science, based in Hoboken, New Jersey, is the North American distributor for Pycnogenol brand French maritime pine bark extract on behalf of Horphag Research. Pycnogenol is